Updates are available Correction dated 2021-07-22
Click to view Correction: https://doi.org/10.1186/s12872-021-02118-y
-
Authors
Ye, Nan
Yang, Lijiao
Wang, Guoqin
Bian, Weijing
Xu, Fengbo
Ma, Changsheng
Zhao, Dong
Liu, Jing
Hao, Yongchen
Liu, Jun
Yang, Na
Cheng, Hong https://orcid.org/0000-0002-7908-3333
,
-
Funding
Funding for this research was provided by:
American Heart Association
Chinese Society of Cardiology
Pfizer
AstraZeneca
- License Information
-
More Information
Article History
Received: 18 May 2020
Accepted: 9 August 2020
First Online: 20 August 2020
Change Date: 22 July 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12872-021-02118-y
Ethics approval and consent to participate
: Institutional review board approval was granted for the aggregate data set for research and quality improvement by the Ethics Committee of Beijing Anzhen Hospital, Capital Medical University. As this was a large population-based study, approval from the Ethics Committee of Beijing Anzhen Hospital, Capital Medical University, included a waiver of informed consent.
: Not applicable.
: The authors declare that they have no competing interests.
